Report an error   

HERDIN Record #: NCR-JRRMMC-11241112112293 Submitted: 24 November 2011 Modified: 29 August 2012

A cross-sectional study on the quality of life of Filipino psoriasis patients versus those with other cutaneous diseases.

Elizabeth Amelia V. Tianco

See More

Psoriasis is a chronic relapsing skin disease that has a major input on a patient's quality of life (QOL). It interferes with daily functions, generates psychological suffering and disrupts social relationships. The impact of psoriasis on a patient is not directly related to the overall area affected, but more to the site distribution and the attitudes of the patient.

STUDY DESIGN: Cross-Sectional Study

STUDY SETTING: Dermatology Out-Patient Department, Jose R. Reyes Memorial Medical Center

A total of 110 psoriasis patients were seen consecutively and were not necessarily new patients.

A total of 187 Filipino patients representing both psoriasis and non-psoriasis groups, completed a modified non-disease specific measure of health-related quality of life (Medical Outcomes Study [MOS]). Responses were compared both groups and subjected to a cross-sectional analysis.

There were significant differences in the quality of life responses of patients with psoriasis and those with other cutaneous diseases. For the psoriasis patient, the disease is not simply a cosmetic nuisance.

This local study has demonstrated that most Filipino psoriatics are burdened by the fact that their condition is not simply limited to the skin alone, but affects their total being. This problem of diminished life quality poses challenges to dwell into behavioral medicine researches, to promote an alliance between doctor and patient, and to address public health issues regarding psoriasis.

Publication Type
Research Report
October 1-December 31, 1999


General Objective:
To describe the impact of psoriasis on the quality of life of Filipino patients afflicted with the disease and compare it with those Filipino patients with other cutaneous diseases.

LocationLocation CodeAvailable FormatAvailability
Medical Library, 5/F Training and Research Office, Jose R. Reyes Memorial Medical Center Abstract Print Format
1. Molin, L . "Psoriasis. A study of the course and degree of severity, joint involvement, socio-medical conditions, general morbidity and influences of selection factors among previously hospitalized psoriatics." Acta Derm Venereol Suppl (Stockh) 53(72): 1-125, 1973
2. Ramsay, B , O, M . "A survey of the social and psychological effects of psoriasis" Br J Dermatol 118, 195-206, 1988
3. Finlay, A Y. Psychological impact of skin disease. Horizons in medicine 4 London: McGraw-Hill, 1993. 172-9.
4. Jobling, R . "Psoriasis: a preliminary questionnaire study of sufferer" Clin Exp Dermatol 1(3): 233-6, 1976
5. Jowett, S , Ryan, T . "Skin disease and handicap: an analysis of the impact of skin conditions" Soc Sci Med 20, 425-9, 1985
6. Gupta, M A, Gupta, A K, Schork, NJ, et al . "A psychocutaneous profile of psoriasis patients who are stress reactors: a study of 127 patients" Gen Hosp Psych 11(3): 166-73, 1989
7. Hughes, J E, Barraclough, B M, Hamblin, LG, et al . "Psychiatric symptoms in dermatology patients" Br J Psychiatry 143, 51-54, 1983
8. Matussek, P , Agerer, D , Seibt, G . "Agression in depressiveness and psoriatics" Psychother Psychosom 43, 125-5, 1985
9. Rapp, S R, Exum, M L, Reboussin, DM, et al . "The physical, psychological and social impact of psoriasis" J Health Psychol 2(4): 525-37, 1997
10. Sanborn, P R, Sanborn, C J, Cimbolic, P., et al . "Suicide and stress-related dermatoses" Dis Nervous Syst 33(6): 391-4, 1972
11. Finlay, A Y, Kelly, S E. "Psoriasis - an index of disability" Clin Exp Dermatol 12, 8-11, 1987
12. Fleischer, Jr, A B, Feldman, S R, Rapp, S R. The magnitudes of skin disease in the United States. Dermatologic Clinics Philadelphia: W.B. Saunders, 2000. 15-21.
13. Finlay, A Y, Coles, E C. "The effect of severe psoriasis on the quality of life of 369 patients" Br J Dermatol 132(2): 236-44, 1995
14. Finlay, A Y, Khan, G K. "Dermatology life quality index (DLQI): a simple practical measure for routine clinical use" Clin Exp Dermatol 19, 210-16, 1994
15. Lewis-Jones, M S, Finlay, A Y. "The children" Br J Dermatol 132, 942-9, 1995
16. Finlay, A Y, Khan, G K, Luscombe, DK, et al . "Validation of sickness impact profile and psoriasis disabilityindex in psoriasis" Br J Dermatol 123, 751-6, 1990
17. Root, S , Kent, G , Al-Abarde, MS K. "The relationship between disease severity, disability and psychosocial distress in patients undergoing PUVA treatment for psoriasis" Dermatology 189, 234-7, 1994
18. Finlay, A Y, Henley, L A. "Quality of life and cost-effectiveness of treatment" J Dermatol Treat 8, 28-9, 1997
19. Stewart, A L, Greenfield, S , Hayds, RD, et al . "Functional status and well-being of patients with chronic conditions: results from the medical outcomes study" JAMA 262, 907-13, 1989
20. Ware, J E, Snow, K K, Kosinski, M, et al . SF-36 health survey manual and interpretation guide. Boston: The Health Institute, New England Medical Center, 1993.
21. McKenna, K E, Stern, MRCP , Stern, R S. "The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort" J Am Acad Dermatol 36, 388-94, 1997

Copyright © One Window Project 2020. All rights reserved.